Innovative Trial Design & Master Protocols: Lisa Lavange | Pod of Asclepius

Lisa LaVange (Gillings School of Global Public Health at the University of North Carolina at Chapel Hill) was the 2018 American Statistical Association (ASA) president and the director of the Office of Biostatistics in the Center for Drug Evaluation and Research (CDER) at the FDA.
She give a high-level overview of issues surrounding Innovative Trial Design and Master Protocols. A great listen for anyone wanting to be introduced to the subject or (for those already familiar) interested in its growing breadth of applications.
#datascience #statistics #biopharm #pharma #FDA